Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.
about
Pneumococcal carriage and antibiotic susceptibility patterns from two cross-sectional colonization surveys among children aged <5 years prior to the introduction of 10-valent pneumococcal conjugate vaccine - Kenya, 2009-2010The role of vaccination in preventing pneumococcal disease in adultsThe prevalence and risk factors for pneumococcal colonization of the nasopharynx among children in Kilifi District, KenyaParapneumonic empyema deaths during past century, Utah.Genetic characterisation of Malawian pneumococci prior to the roll-out of the PCV13 vaccine using a high-throughput whole genome sequencing approachEpidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.Genome evolution driven by host adaptations results in a more virulent and antimicrobial-resistant Streptococcus pneumoniae serotype 14Streptococcus pneumoniae serotype 3 among Costa Rican children with otitis media: clinical, epidemiological characteristics and antimicrobial resistance patterns.Effect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infants.Realtime PCR is more sensitive than multiplex PCR for diagnosis and serotyping in children with culture negative pneumococcal invasive diseaseDynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease.Simulated effect of pneumococcal vaccination in the Netherlands on existing rules constructed in a non-vaccinated cohort predicting sequelae after bacterial meningitis.The effect of Haemophilus influenzae type b and pneumococcal conjugate vaccines on childhood pneumonia incidence, severe morbidity and mortality.Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers.Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology.Re-emergence of the type 1 pilus among Streptococcus pneumoniae isolates in Massachusetts, USA.Sequence diversity within the capsular genes of Streptococcus pneumoniae serogroup 6 and 19.Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands.Bacterial causes of empyema in children, Australia, 2007-2009.The status of invasive pneumococcal disease among children younger than 5 years of age in north-west Lombardy, Italy.Towards the 13-valent pneumococcal conjugate universal vaccination: effectiveness in the transition era between PCV7 and PCV13 in Italy, 2010-2013Cost-effectiveness of new pneumococcal conjugate vaccines in Turkey: a decision analytical model.Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendarCost-effectiveness and cost utility analysis of three pneumococcal conjugate vaccines in children of PeruParental decline of pneumococcal vaccination and risk of pneumococcal related disease in childrenNasopharyngeal pneumococcal carriage of children attending day care centers in Korea: comparison between children immunized with 7-valent pneumococcal conjugate vaccine and non-immunized.Hospitalization for invasive pneumococcal disease in a national sample of children with sickle cell disease before and after PCV7 licensure.Mortality reductions for older adults differ by race/ethnicity and gender since the introduction of adult and pediatric pneumococcal vaccinesClinical and economic burden of invasive pneumococcal disease in adults: a multicenter hospital-based study.Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?Serotypes of Streptococcus pneumoniae isolates from children with invasive pneumococcal disease in Turkey: baseline evaluation of the introduction of the pneumococcal conjugate vaccine nationwide.Extensive horizontal gene transfer in ureaplasmas from humans questions the utility of serotyping for diagnostic purposes.Retrospective review of invasive pediatric pneumococcal diseases in a military hospital in the southern region of Saudi Arabia.An evaluation of emerging vaccines for childhood pneumococcal pneumonia.Evolution of the epidemiology of pneumococcal disease among Utah children through the vaccine era.Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates collected at a Chinese hospital from 2011 to 2013.Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine.Corynebacterium accolens Releases Antipneumococcal Free Fatty Acids from Human Nostril and Skin Surface Triacylglycerols.10-valent pneumococcal non-typeable Haemophilus influenzae protein-D conjugate vaccine (PHiD-CV) induces memory B cell responses in healthy Kenyan toddlers.Clinical characteristics of the patients with bacteremia due to Moraxella catarrhalis in children: a case-control study.
P2860
Q28359834-7759FD31-8F4B-410F-9781-9B900A93469DQ28396749-24193415-B45F-421A-97C0-1C1138CB0793Q28731923-A87CE4C5-6180-43DD-A799-025ED2A44B14Q30374152-D3267B7B-D1A8-48E8-84BD-F17317C7EA9EQ30421183-EE894E70-2A28-4EF5-A788-B730F65FF746Q30431534-5603A2F1-67E2-4CF0-96E6-9FA5D55429FAQ33429266-5D78E608-4FDA-43B5-A990-1BF6A8DF3C36Q33493595-E314C91B-8530-4DA5-9EA5-0945D34199F1Q33525194-6E1B6367-6313-4B4D-AE15-58A564B6CD65Q33533300-0254FB11-189F-4672-B33C-49D18315ECCEQ33551026-A7CFF07F-4E7C-499E-8F38-6A39AB1734A9Q33683925-29C33F42-22E3-4292-9584-17816557CDCCQ33754518-BA83888E-44F9-457D-A33E-996D98B38F03Q33909172-22B9D6EE-10F3-4569-BCA4-9B77DE9E5297Q33947633-482C4256-DC77-4CA8-9244-DBB9750EDBC1Q33965380-D4E6198C-B2F3-4899-854F-18468899BC51Q34031836-5A9C56A3-A51C-4BDA-B895-4A599343908CQ34194058-5E427AFD-45AF-487D-B699-5359011A68B6Q34224472-B5A9AFB2-633A-4988-A1C3-9576BAD1A507Q34254800-F29D9B19-5F75-40D4-A87C-4CB34C696E90Q34271575-CD9D8371-034B-4B89-B04F-86623468EA0EQ34471089-C01FDF35-1D28-4EBF-8C12-B3F564A1415BQ34484173-8BD8FC48-DCDF-4DC4-8E1B-B3CF9C2227DFQ34493821-16A7CEA5-E36E-4361-9927-F911136763B4Q34516718-1296FC4C-FCC6-418E-9841-BC1736D1FA6DQ34539923-CC3BA20B-D95C-4D53-9E3E-5AF4E33206B2Q34591762-1C4B6806-3FD8-4ED7-AC36-9A2AA3878722Q34663884-E5072641-76A3-4DA4-A4F2-C6F5761F28B7Q34704745-75B2A388-1F98-4398-9A70-C9ECA992E981Q34798448-7B303657-5990-4E27-9BFC-A87D19D8538DQ35066491-6EEC4DBB-8E67-4814-975B-4670C03C54F5Q35139701-F1690E38-E69A-4A64-9EF7-81793F0F605AQ35245475-54810D19-7C83-4241-99FE-2EE420C5DB17Q35595931-ABEF48FD-724B-4440-9993-CD8430E3A0F8Q35619069-D45ED2D2-B68A-4F3A-9F8E-38DE01F17FCBQ35737956-D55A61E4-373E-4FF9-8D12-E827B8E812C2Q35785952-348D1129-1BF1-436E-A5C1-7023940F5828Q35886154-55AE34E7-AC2E-4F42-8113-2332B314C3E5Q35893171-779565AE-4787-44C6-9AD4-DA3D305496B4Q35919024-D814A478-D351-4605-9E52-2D42D9151DC3
P2860
Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Invasive pneumococcal disease ...... tion--eight states, 1998-2005.
@en
type
label
Invasive pneumococcal disease ...... tion--eight states, 1998-2005.
@en
prefLabel
Invasive pneumococcal disease ...... tion--eight states, 1998-2005.
@en
P1476
Invasive pneumococcal disease ...... ction--eight states, 1998-2005
@en
P304
P577
2008-02-01T00:00:00Z